| The evolution of antibiotic resistance is associated with collateral drug phenotypes in Mycobacterium tuberculosis NJE Waller, CY Cheung, GM Cook, MB McNeil Nature Communications 14 (1), 1517, 2023 | 25 | 2023 |
| An amiloride derivative is active against the F1Fo-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis K Hards, CY Cheung, N Waller, C Adolph, L Keighley, ZS Tee, LK Harold, ... Communications Biology 5 (1), 166, 2022 | 25 | 2022 |
| Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis MB McNeil, CY Cheung, NJE Waller, C Adolph, CL Chapman, NEJ Seeto, ... Frontiers in Cellular and Infection Microbiology 12, 980844, 2022 | 4 | 2022 |
| KatG inactivation generates vulnerabilities in isoniazid resistant strains of Mycobacterium tuberculosis XY Wang, WJ Jowsey, CY Cheung, NE Seeto, NJE Waller, MT Chrisp, ... bioRxiv, 2023.12. 07.570702, 2023 | | 2023 |
| Identification and exploitation of collateral drug susceptibilities in Mycobacterium tuberculosis NJE Waller University of Otago, 2023 | | 2023 |
